Current Issue

View Larger Image

Past Issues Free Subscriptions
Sponsored
Keywords



Search Results - Massachusetts
 More »

  • Biotechs Need to Walk the Walk on Drug Value
    In June 2012, Massachusetts joined with Abbott, Biogen Idec, EMD Serono, Janssen, Merck & Co., Pfizer, and Sunovion Pharmaceuticals to form the Massachusetts Neuroscience ...
    5-15-2013
  • Induced Pluripotent Stem Cells: A U.S. Patent Landscape Analysis
    ... ). 61% of all iPSC patenting activating is clustered around four geographical areas: Massachusetts (Boston), California, Japan (almost entirely from Kyoto), and Madison, Wisconsin. ...
    5-13-2013
  • Study: Protein Secreted by Certain Fat Cells Can Trigger RA
    Working in collaboration with researchers at Fukushima Medical University School of Medicine in Japan, Massachusetts General Hospital for Children, and Brigham and Women's ...
    5-8-2013
  • It's Not Just Willpower: Genes Play a Role in Bypass Surgery...
    a lot of weight, some lose very little, but most lose an average amount postsurgery. But why? According to new research out of Massachusetts General Hospital, it could be genetic. ...
    5-3-2013
  • Destructive Decision-Making
    Here are six of those patterns. [© apops - Fotolia.com] We often use the "Dawn breaks ..." expression here in Massachusetts to describe the behavior of our politicians as ...
    5-1-2013
  • GEN | Biolinks
    ... Marcor Development Marina Biotech, Inc Maryland DBED Massachusetts Alliance for Economic Development Massachusetts Biomedical Initiatives Massachusetts Biotechnology Council ...
  • E&Y: Biotechs Must Walk the Walk on Drug Value
    In June 2012, Massachusetts joined with Abbott, Biogen Idec, EMD Serono, Janssen, Merck & Co., Pfizer, and Sunovion Pharmaceuticals to form the Massachusetts Neuroscience ...
    4-22-2013
  • EMD Serono Expanding R&D Hub in Billerica, MA
    in Rockland, MA. EMD Serono had 854 employees across Massachusetts as of last year, according to the Massachusetts Biotechnology Council's Biopharma Industry Snapshot 2012. ...
    4-18-2013
  • Performing "Informative Clinical Trials" in Mice
    them as if you were manipulating little humans, so to speak, without ever putting patients at risk," says Dale Greiner, Ph.D., of the University of Massachusetts Medical School. ...
    4-17-2013
  • NanoString Nabs License to Liver Cancer Gene Signature
    ... Golub and a group of researchers from the Dana-Farber Cancer Institute, the Icahn Sinai School of Medicine at Mount Sinai, Massachusetts General Hospital, Massachusetts Institute ...
    4-17-2013
  • Transplanted Bioengineered Kidneys Successfully Produce Urine
    neonatal kidney cells. [Ott Laboratory, Massachusetts General Hospital Center for Regenerative Medicine] Researchers at the Massachusetts General Hospital (MGH) bioengineered rat ...
    4-15-2013
  • Bioengineered Kidney Makes Urine
    Scientists at the Massachusetts General Hospital in Boston have created a bioengineered ... Scientists at the Massachusetts General Hospital in Boston have created a bioengineered ...
    4-15-2013
  • BMS Grows Biologics in $250M Expansion
    ... Massachusetts Life Sciences Center (MLSC), spokesman Angus McQuillan told GEN earlier today. MLSC is the quasi-public agency that implements the 10-year, $1 billion Massachusetts ...
    4-11-2013
  • AstraZeneca, Moderna in Up to $420M+ mRNA Drug Development Deal
    ... Headquartered in Cambridge, MA, privately held Moderna was founded in 2010 by Flagship VentureLabs in association with scientists from Harvard University and Massachusetts ...
    3-21-2013
  • Blueprint Medicines Collaboration Zeroes In on Cancer Targets
    Trust Sanger Institute and the Massachusetts General Hospital Cancer Center to ... In collaboration with the Massachusetts General Hospital Cancer Center, the Sanger ...
    3-19-2013
  • More »

    Journal Articles

  • Genotypic and Phenotypic Analysis of Clostridium difficile Correlated...
    Matthew H. Samore, Lata Venkataraman, Paola C. Degirolami, Michelle M. Merrigan, Stuart Johnson, Dale N. Gerding, Yehuda Carmeli, Stephan Harbarth
    Microbial Drug Resistance
    examined 83 nosocomial C. difficile isolates recovered at a tertiary care center in Boston, Massachusetts. MICs were determined by E-test methodology using modified Brucella agar. ...
  • Prepregnancy Weight, Gestational Weight Gain, and Risk of Growth...
    Tiffany A. Moore Simas, Molly E. Waring, Xun Liao, Anne Garrison, Gina M.T. Sullivan, Allison E. Howard, Janet R. Hardy
    Journal of Women's Health
    Methods: Subjects were a retrospective cohort of 11,203 live birth singletons delivered at 22-44 weeks at a Massachusetts tertiary care center between April 2006 and March 2010. ...
  • Addressing Obesity in Pregnancy: What Do Obstetric Providers...
    Sharon J. Herring, Deborah N. Platek, Patricia Elliott, Laura E. Riley, Alison M. Stuebe, Emily Oken
    Journal of Women's Health
    Methods: In 2007-2008, we surveyed 58 practicing obstetricians, nurse practitioners, and certified nurse-midwives at a multispecialty practice in Massachusetts. We administered a ...
  • Physical Activity and Gestational Diabetes Mellitus among Hispanic...
    Lisa Chasan-Taber, Michael D. Schmidt, Penelope Pekow, Barbara Sternfeld, Joann E. Manson, Caren G. Solomon, Barry Braun, Glenn Markenson
    Journal of Women's Health
    care patients in western Massachusetts from 2000 to 2004. Prepregnancy, early pregnancy, and midpregnancy physical activity was assessed using the Kaiser Physical Activity Survey. ...

GEN Webinars

View »

GEN Web Briefs

View »

GEN Poll

More » Poll Results » Archive »

Genome Sequencing and Patient Autonomy

Do you think ACMG’s recent recommendations for reporting incidental clinical sequencing results undermine patient autonomy?

Suggest a Poll